Morgan Stilgenbauer

Enigma
DISC Type : idc

Senior Scientist, Investigative Toxicology at Tessera Therapeutics

Boston, Massachusetts, United States

Overview

Morgan Stilgenbauer is a Senior Scientist in Investigative Toxicology at Tessera with a PhD from Kent State University. Her expertise is in oncology drug development, focusing on targeted protein degradation for previously "undruggable" targets. Colleagues have described her as an inquisitive scientist and a major contributor to her programs.

Her graduate research involved synthesizing novel Platinum(IV) prodrugs designed to target and overcome drug resistance in ovarian cancer stem cells.

Personality Overview

Hard To Convince

Fast Follower

Friendly Yet Blunt

They are likely to ask many questions and look heavily for supporting proof as well as information.  They can sound friendly and charming but can quickly change gears to become inquisitive and probing  They are generally strong communicators and are not easy to convince.

Topics They Care About

Targeted Protein Degradation
A core focus of her postdoctoral and industry research, developing small molecules, molecular glues, and PROTACS to degrade oncogenic proteins like c-MYC.
Oncology Drug Development
Her entire career, from graduate work on ovarian cancer to industry roles, has been dedicated to discovering and advancing novel cancer therapeutics.
Investigative Toxicology
As a Senior Scientist in this field at Tessera, understanding the mechanisms of drug toxicity and ensuring therapeutic safety is her primary professional focus.

Media Appearances

Morgan has no verified media appearances

Work History

1-2026
Senior Scientist, Investigative Toxicology at Tessera Therapeutics
2-2024 - 1-2026
Scientist II at Tessera Therapeutics
10-2022 - 2-2024
Research Scientist I, Cell Biology at 76Bio, Inc.
2-2021 - 10-2022
Postdoctoral Fellow at MIT Koch Institute for Integrative Cancer Research
7-2016 - 7-2020
Graduate Research Assistant at Kent State University

Education

7-2016 - 8-2020
Doctor of Philosophy - PhD from Kent State University
8-2012 - 5-2016
Bachelor of Science - BS from Walsh University

More Information

Social Presence :

Prographics :

Exp : 9 Location : Boston, Massachusetts, United States Job Level : N/A Designation : Senior Scientist, Investigative Toxicology at Tessera Therapeutics
URL has been copied!

Insights For Selling To Morgan

During A Call Or A Meeting

DO's

  • Help them realize that any personal risk in making this decision is far less compared to what the results could mean for them
  • Leverage 'negging', or the art of asking negative questions like "you must not be convinced yet..."
  • Build rapport slwly without rushing, it will come handy to handle hard questions later

DONT's

  • Don’t brush off any concerns, take all questions seriously. They are easily deterred
  • Avoid long presentations and just 'high-level' value proposition, dive into the details
  • Don’t be too objective but make sure to pad your storytelling with data points

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Morgan is

  • Proven value, strong objective evidence are important for them, rapport can impact decisions a little.
  • Will you ever get a clear answer from Morgan

  • They are practical and friendly, but can give a clear response with a little prodding

Insights For Deal Planning

    How fast (or slow) will Morgan move?

  • They like to be detailed, so unless they develop strong conviction, they can take their time to arrive at decisions
  • Can Morgan take some risk or not?

  • They evaluate their decisions systematically and do not take risks that often, unless you can get them to develop strong conviction

You And Morgan

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.